















































The free radical theory of aging proposes that free 
radicals accelerate the accumulation of damaged 
structures over time leading to impaired cellular and 
organismal function during aging [1]. Oxidative stress is  
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driven by reactive oxygen species mainly produced in 
mitochondria. Superoxide anions, being produced at 
complex I and III of the electron transport chain [2], are 
primarily detoxified in mitochondria by the manganese 
dependent form of superoxide dismutase SOD2 (also 
called MnSOD). It has been shown that Sod2 over-
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versa, impairment or deletion of SOD2 expression 
induced a significant shortening of the lifespan of 
Drosophila [5; 6] and mice [7; 8].  
 
Mice carrying a heterozygous deletion of Sod2 (Sod2
+/-) 
are viable but show increased oxidative stress, increased 
nuclear and mitochondrial DNA modifications, 
impaired mitochondria function, and increased 
apoptosis rates [9-13]. Sod2
+/- mice exhibit slightly 
increased rates of cancer but no other features of 
accelerated aging and have a normal lifespan [13]. 
These studies indicated that a decrease in the oxidative 
damage defense system by itself does not induce a 
significant increase in aging pathology in mice. 
However, the Sod2
+/-  mouse provided a unique 
experimental system to analyze whether an impaired 
anti-oxidant defense can cooperate with other molecular 
causes of aging and disease. Although Sod2 
polymorphisms were not associated with longevity of 
centenarians [14], the investigation of this question 
appears to be highly relevant since SNPs in various 
components of the oxidative stress pathway are 
associated with phenotypes of human aging [15]. 
 
There is growing evidence that an accumulation of 
telomere dysfunction and DNA damage contributes to 
human aging  [16; 17]. Several lines of evidence 
indicate that reduced SOD2 levels and increased ROS 
could influence cellular and organismal aging in the 
context of telomere shortening and DNA damage 
accumulation:  
 
(i) Experimental data have shown that ROS can induce 
different lesions in nuclear DNA including oxidized 
bases, strand breaks and mutations [18-21]. Thus, ROS 
may contribute to the generation of nuclear DNA 
damage and the evolution of aging pathology at 
organismal level.  
 
(ii) Telomere shortening limits the proliferative capacity 
of human cells to 50-70 cell divisions by induction of 
senescence or apoptosis [22-25]. Replicative senescent 
cells show increased ROS levels [26; 27] and increased 
oxidative DNA damage [28] indicating that senescence 
can accelerate ROS induced DNA damage. In addition, 
increased ROS levels and oxidative modifications to 
DNA have also been implicated as causal factors 
inducing senescence [19; 27; 29-33]. In agreement with 
this hypothesis, it was shown that increased ROS 
accelerate the rate of telomere shortening in cell culture 
[34] and that oxidative stress severely limits the replicative 
potential of mouse cells independently of the presence of 
telomerase [35].  It remains yet to be investigated 
whether ROS and telomere shortening cooperate to 
induce an accumulation of DNA damage and 
senescence in aging tissues. 
 
(iii) SOD2 level could influence the induction of 
checkpoints in response to DNA damage or telomere 
dysfunction. It has been shown that decreased SOD2 
expression accelerated p53-induced apoptosis [36], 
whereas up-regulation of SOD2 protected cells from 
apoptosis by stabilization of mitochondrial membranes 
[37]. Both mechanisms could be relevant to aging 
induced by telomere dysfunction, since the impairment 
of organ maintenance in response to telomere 
dysfunction is associated with activation of the p53/p21 
signaling pathway and increased rates of apoptosis [38-
41]. 
 
Laboratory mouse strains are of limited use to identify 
factors that accelerate aging in the context of telomere 
dysfunction and DNA damage, since laboratory mice in 
comparison to humans, have very long telomeres [42]. 
Laboratory mice show some evidence for an accumu-
lation of DNA damage during aging [43] However, 
biomarker studies revealed that the level of telomere 
dysfunction and DNA damage in aging laboratory mice 
is low compared to human aging [16]. Telomerase 
knockout (mTerc
-/-) mice provided an experimental 
system to study aging induced by telomere dysfunction 
and DNA damage [16; 44; 45]. Considering that 
oxidative stress was shown to shorten telomeres [46], 
limit stem cell function [47], and induce DNA damage 
and senescence (see above), we hypothesized that Sod2 
haploinsufficiency could affect stem cell pools and 
aging of telomere dysfunctional mice.  
 
Here we analyzed consequences of a heterozygous 
deletion of Sod2 on aging of telomerase wild-type mice 
with long telomeres and third generation (G3) mTerc
-/- 
mice with dysfunctional telomeres. The study shows 
that heterozygous Sod2 deletion does not affect stem 
cell function, organ maintenance and lifespan of 
telomere dysfunctional mice. These results indicate that 
a reduction in SOD2-dependent anti-oxidant defense 





Heterozygous deletion of Sod2 reduces SOD2 protein 
levels and antioxidant capacity 
 
Sod2
+/- mice were crossed through 3 generations with 
telomerase knockout mice (Suppl. Figure 1) to generate 
the following cohorts: mTerc
+,  Sod2
+/- mice (n=31); 
mTerc
+, Sod2





+/+ mice (n=38). The mTerc
+ 
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+/+ and mTerc
+/- 
mice with long telomeres since they do not 
phenotypically differ from each other. 
 
In  mTerc
+ mice, heterozygous deletion of Sod2 
correlated with significantly decreased SOD2 protein 
levels in liver, whereas the decrease in brain and bone 
marrow did not reach statistical significance (Figure 
1A-C). SOD2 protein levels were slightly but not 





+/+ mice. A further decrease 
occurred in G3 mTerc
-/-,  Sod2
+/- mice resulting in a 
significant decrease in SOD2 protein levels in all 
investigated organs of these mice compared to  mTerc
+, 
Sod2
+/+ mice (Figure 1A-C). 
 
To investigate functional consequences of heterozygous 
Sod2 deletion, levels of reactive oxygen species (ROS) 
were analyzed in muscle and hematopoietic cells. For 
this purpose we used (i) dihydroethidium (DHE), which 



































response to oxidation;  (ii) mitosox,  which localizes  to 
mitochondria and exhibits red fluorescence after 
superoxide-induced oxidation, and (iii) dichloro-dihydro-
fluorescein (DCFDA), which detects a wide range of 
ROS after removal of its acetate group by oxidation. 
Heterozygous deletion of Sod2 was associated with 
increased basal superoxide levels in muscle cells of both 
mTercmTerc
+ and G3 mTerc
-/- mice (Figure 1D). Sod2 
gene status had no significant effect on basal ROS levels 
in bone marrow derived stem and progenitor
 cells (LSK 
cells: Lineage-negative, Sca1-positive, c-Kit-positive, 
data not shown). However, stress induced ROS level after 
treatment with antimycinA (a complex III inhibitor that 
induces superoxide production) were elevated in bone 
marrow derived LSK and myeloid cells of G3 mTerc
-/-, 
Sod2
+/- mice compared to mTerc
+, Sod2
+/+ mice (Figure 
1E, F). In accordance with the data on SOD2 protein 
expression, these data on antimycinA induced ROS in 
hematopoietic and myeloid cells suggested that Sod2 
haploinsufficiency cooperated with telomere dysfunction 
to impair ROS detoxification in G3 mTerc
-/-, Sod2






















































   
















































Sod2 heterozygous deletion does not increase 
mitochondrial dysfunction in aging G3 mTerc
-/- mice 
 
Mitochondria are the major source of ROS production 
in cells and a decrease in anti-oxidant defense can 
induce mitochondrial damage leading to a decrease in 





































































ement with these studies, muscles from 8-11 month old 
mTerc
+,  Sod2
+/- mice had lower state III respiration 
rates (ADP dependent, normalized to the mitochondrial 
mass) and lower maximum respiration rates (induced 
with the mitochondrial uncoupler FCCP) compared to 
fibers from mTerc
+,  Sod2
+/+ mice (Figure 2A). 
However, this decrease was ameliorated in muscle 
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-/-,  Sod2
+/- mice 
(Figure 2A). Treatment with rotenone, a complex I 
inhibitor, reduced but did not completely abolish 
respiration rates of the muscles fibers, indicating 
ongoing complex I independent respiration. This 
complex I independent respiration was also significantly 
reduced in Sod2
+/- mice compared to wild type controls 
(Figure 2A). Again, this Sod2-dependent reduction in 













































   
 
 
An analysis of basal respiration rates and maximal induced 
respiration (in response to FCCP treatment) did not reveal 
a significant influence of Sod2 gene status on the 
respiratory capacity of total bone marrow cells of 8 to 11 
month old mTerc
+ and G3 mTerc
-/- mice (Suppl. Figure 
2A). In this compartment, mitochondria from G3 mTerc
-/- 
mice showed an increased maximal respiratory capacity 
(FCCP-induced) compared to mTerc
+ mice suggesting that 
telomere dysfunction induced adaptive responses that 
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To analyze the basal levels of oxidative purine 
modifications in DNA from total bone marrow cells, we 
used an alkaline elution assay in combination with 
formamidopyrimidine-DNA glycoslyase (Fpg) as a probe 
[49; 50]. The enzyme recognizes 7,8-dihydro-8-
oxoguanine (8-oxodG) among other oxidative purine 
lesions in nuclear DNA [51]. The technique avoids the 
spontaneous generation of 8-oxodG during DNA 
isolation and hydrolysis [52]. Our analysis revealed an 
increase of the basal level of oxidative damage in the 
nuclear DNA of G3 mTerc
-/- mice compared to mTerc
+ 
mice, but heterozygous deletion of Sod2 had no influence 
(Figure 2B).  
 
Increased ROS levels have been shown to induce DNA 
double strand breaks and senescence in response to 
prolonged interferon stimulation [19]. Here, the 
prevalence of DNA double strand breaks was analyzed 
by γH2AX staining. γH2AX forms foci at DNA breaks 
































[53-56].  DNA damage foci were analyzed in intestinal 
crypts (a proliferative stem cell compartment, which is 
highly sensitive to telomere dysfunction). In agreement 
with previous studies, 12-18 month old G3 mTerc-/- mice 
exhibited significantly higher levels of DNA damage 
compared to age-matched mTerc+ mice (Figure 2C-D). 
However, heterozygous deletion of Sod2 did not increase 
accumulation of DNA damage foci (Figure 2C-D).  
 
Increasing ROS levels can accelerate telomere 
shortening in cell culture systems [34; 46]. As expected, 
an analysis of telomere length showed shorter telomeres 
in liver (Figure 2E) and intestine (Suppl. Figure 2B) of 
12 -18 month old G3  mTerc
-/- mice compared to age-
matched  mTerc
+ mice. However, Sod2 haplo-
insufficiency did not accelerate telomere shortening 
(Figure 2E and Suppl. Figure 2B). In agreement with 
the data on oxidative DNA damage, γH2AX-foci, and 
telomere length, the expression level of serum markers 
of DNA damage and telomere dysfunction [16] was 
increased in 12 to 18 month old G3 mTerc
-/- mice 
compared to age-matched mTerc
+ mice, but Sod2 
haploinsufficiency did not increase serum levels of 
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and the shortening in lifespan of telomere dysfunc-
tional mice 
 
Previous studies have shown that telomere dysfunction 
impairs the maintenance of high turnover organs in 
aging  mTerc
-/- mice, specifically affecting the 
hematopoietic system and the intestinal epithelium [38-
40]. In agreement with these studies, 12-15 month old 
G3 mTerc
-/- mice compared to age-matched mTerc
+  
mice exhibited anemia (Figure 3A), a reduction in bone 
marrow derived B-lymphopoiesis (Figure 3B, Suppl. 
Figure 3A-C), a reduction in thymic T-lymphopoiesis 
(Suppl. Figure 3D, E), and an impaired maintenance 
and function of hematopoietic stem cells (HSCs) 
(Figure 3C, D). Heterozygous deletion of Sod2 
accentuated the decrease in mature B cells in aging G3 
mTerc
-/- mice (Figure 3B) but otherwise did not show 
consistent effects on hematopoietic parameters in 
mTerc
+ and G3 mTerc
-/- mice. As shown in previous 
studies [38; 40; 45], aging telomere dysfunctional mice 
developed a severe atrophy of intestinal epithelia 
compared to age-matched mTerc
+ mice (Figure 3E, F). 
Sod2 heterozygosity did not increase the severity of 
crypt atrophy in aged telomere dysfunctional mice 
(Figure 3E, F).  
 
In line with previous results, an impairment in organ 
maintenance was associated with a shortened lifespan of 
telomere dysfunctional mice compared to mTerc
+ mice 
(Figure 4 A-C) correlating with an age-dependent 
decline in body weight (Figure 4 D, E). Heterozygous 
deletion of Sod2 did not alter weight curves (Figure 4D, 
E) or survival (Figure 4 A-C) of telomere dysfunctional 
mice. Specifically, no survival difference was observed 
between G3 mTerc
-/-  Sod2
+/- mice compared to G3 
mTerc
-/-, Sod2
+/+ mice (median lifespan 72.3 and 69.1 
weeks respectively, p=0.75 Figure 4A). Sod2 
heterozygosity did also not affect the incidence of 
spontaneous cancer in aging G3 mTerc
-/- mice and 
mTerc
+ mice during the observation period of 20 




The current study shows that SOD2 reduction does not 
affect stem cell function, organ maintenance, and 
lifespan of telomere dysfunctional mice. These results 
contrast with studies on mouse models of diseases, 
where  Sod2  hemizygosity exacerbated disease 
phenotypes as (i) increasing the formation of neurotoxic 
plaques and tangles in APP and Tg2576 transgenic [57; 
58], (ii) reducing the lifespan of G93A transgenic mice 
– a model for amytrophic lateral sclerosis [59], (iii) 
increasing diabetic neuropathy in db/db mouse [60], and 
(iv) increasing endothelial dysfunction in athero-
sclerosis prone ApoE deficient mice [61]. Together, 
these findings suggest that in contrast to disease 
conditions, telomere dysfunction per se does not 
cooperate with a decrease in anti-oxidant defense to 
impair organ maintenance and lifespan.  
 
Our experiments show that heterozygous deletion of 
Sod2 results in diminished SOD2 protein levels and 
impaired anti-oxidant defense in different organ systems 
of telomere dysfunctional mice including muscle and 
hematopoietic cells. However, this deficiency does not 
lead to an impairment in mitochondrial function in 
aging telomere dysfunctional mice, whereas it reduces 
mitochondrial function in aged mTerc
+ mice. Previous 
studies have shown that mitochondrial dysfunction 
contributes to induction of senescence in fibroblast 
cultures [26; 62]. The maintenance of mitochondrial 
function in G3mTerc
-/-,  Sod2
+/- mice suggests that 
telomere dysfunction might induce adaptive responses 
that protect mitochondria from oxidative damage 
possibly involving activation of repair responses. 
Alternatively, telomere dysfunction may cooperate with 
mitochondria dysfunction in vivo to induce clearance of 
dysfunctional cells, thus maintaining a cellular pool 
with functional mitochondria.  
 
There is an ongoing debate whether mechanisms that 
increase oxidative stress can contribute to an 
accumulation of nuclear DNA damage and aging. 
Studies with cultured human cells suggested that the 
contribution of mitochondrial-derived ROS to the 
generation of oxidative modifications in nuclear DNA is 
small [63]. However, in vivo studies with Sod2 mutant 
mice have shown that Sod2 haploinsufficiency can 
increase the level of oxidative modification to nuclear 
DNA and increase the cancer risk in very old (26 month 
old mice) [13]. In addition, there is evidence that 
impairment of DNA repair systems results in elevated 
ROS-mediated nuclear DNA damage, cellular 
senescence, and cancer formation [33; 64; 65].  
 
In the current study, the maximal lifespan of telomere 
dysfunctional (G3 mTerc
-/-) mice was limited to 19 
months. During this observation period, Sod2 
haploinsufficiency did not accelerate the accumulation 
of oxidative DNA base damage or DNA double strand 
breaks in both telomere dysfunctional mice and mTerc
+ 
mice. These data indicate that heterozyogous deletion of 
Sod2 does not cooperate with telomere dysfunction to 
accelerate the accumulation of nuclear DNA damage. 
The results from previous studies suggest that telomere 
independent factors may cooperate with Sod2 
haploinsufficiency in long lived wild type  mice to 
increase nuclear damage. It appears to be surprising that 
   
www.impactaging.com                 309                                     AGING, March 2009, Vol.1 No.3nuclear DNA damage was not increased in G3 mTerc
-/-, 
Sod2
+/-mice,  although the mice showed increased 
intracellular ROS in muscle and impaired anti-oxidant 
defense in response to stress induced ROS. Possible 
explanations include that (i) removal of oxidative DNA 
lesion in repair proficient mice is sufficiently efficient 
to counteract effects of moderately increased ROS or 
(ii) diffusion of mitochondria derived ROS to the 
nucleus is limited irrespective of Sod2 gene status.  In 
agreement with the data on unchanged rates of nuclear 
DNA damage, the current study did not detect a cancer 
promoting effect of Sod2 deficiency in telomere 
dysfunctional mice and mTerc
+ mice during the 
observation period of 19 month.  
 
Together, the current study provides the first 
experimental evidence that an impairment of SOD2-
dependent anti-oxidant defense does not cooperate with 
telomere dysfunction to aggravate organismal aging.  
 
MATERIALS AND METHODS 
 
Mouse crosses and survival. Sod2
+/- mice [7] acquired 
from Jackson laboratories (stock number 002973) was 
crossed with mTerc
-/- mice  for 3 generations in order to 
create the following experimental cohorts G3 mTerc
-/-, 
Sod2





+/- (n=31) and mTerc
+, Sod2
+/+ (n=34). Mice were 
kept in a pathogen free environment where they had 
free access to food and water. 
 
Mice were sacrificed by CO2 asphyxiation when 
presented deteriorated health condition or loss of 30% 
of body weight. Organs were quickly removed and 
either frozen down in dry ice or fixed in 4% 
paraformaldehyde (PFA) for paraffin embedding. 
 




FACS analysis.  FACS analysis was performed on 
freshly isolated bone marrow cells that were stained for 
15 min on ice with the appropriate antibody cocktail. 
Cells were analyzed using an LSRII or FACS Calibur 
machine. 
 
Bone marrow competitive transplantation. One to three 
young C57/BL6 mice per donor were retroorbitally 
transplanted after lethal irradiation (12Gy) with 8x10
5 
donor (Ly5.2) and 4x10
5 competitor (Ly5.1) bone 
marrow cells. Four 15-months-old male mice per 
genotype were used as donors and four 12-month old 
Ly5.1 female mice were used as competitors in the 
experiment. 
Chimerism was checked at one, 2 and 5 months after 
transplantation in white blood cells collected from 
retroorbital bleeding.   
 
γ-H2AX staining in intestine sections.  Three um 
paraffin sections were stained with primary anti γ-
H2AX (Millipore 06-636) overnight in PBS, washed 
three times and incubated for 30 min with secondary 
anti mouse IgG labeld with Cy7. Slides were kept at 
4°C until analysis. 
 
Oxidative modifications to DNA. Quantification of the 
basal levels of oxidative purine modifications in bone 
marrow cells isolated from the various mouse strains 
was carried out by the alkaline elution assay originally 
described by [49] with modifications reported 
previously [50; 67]. Fpg-sensitive sites detection was 
performed in 1x10
6  bone marrow cells per mouse as 
previously described [68].  
 
ROS measurement in bone marrow cells.  Mitosox 
staining:  Freshly isolated bone marrow cells were 
loaded in staining media with Mitosox (Molecular 
probes. Cat. No. M36008)  5uM final concentration and 
incubated for 30 min at 37°C. The cells were washed 
once with PBS and  antimycinA (Sigma Cat No. 8674) 
was added for a final concentration of 20uM. The cells 
were incubated 10 minutes, filtered and immediately 
analysed by FACS. 
 
DCFDA staining: Freshly isolated bone marrow cells 
were stained for LSK (except for CD34) loaded with 
DCFDA 0.5 uM (Molecular probes Cat. No. C6827) 
and incubated for 5 min at 37°C. The cells were washed 
once with PBS and  antimycinA (Sigma Cat No. 8674) 
was added for a final concentration of 50uM. The cells 
were incubated 10 minutes, filtered and immediately 
analyzed by FACS. 
 
ROS measurement in muscle bundles.  Muscle fibers 
were incubated  with DHE at a final concentration of 40 
µM in PBS for 30 min at 37°C. After staining, the tissue 
was washed in PBS and fixed using 2.2 % 
formaldehyde in 0.1 M Sorensen phosphate buffer (pH 
7.1). Confocal images were collected with 40x 
objective. 
 
Protein analysis. Whole cell extracts were prepared in 
RIPA buffer with cocktail of protease inhibitors and 
reducing agents (NaVO3 1mM, DTT 1mM, PMSF 
1mM, proteinase cocktail inhibitor ROCHE Cat. No. 
11836153001). SOD2 levels were determined using 
AntiSOD2 antibody (Santa Cruz, SC-30080) and actin 
levels with antiActin (Santa Cruz SC-1615). 
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was performed in intact bone marrow cells  and 
permeabilized muscle bundles as described [62; 69]. 
 
Muscle bundles: Respirometry of saponin-
permeabilized muscle fibers was performed with the 
Oxygraph-2k (OROBOROS instruments) using between 
10 and 25 mg of biopsy material. Measurements were 
performed at 37°C in the range of 200-400 µM oxygen, 
to avoid oxygen limitation. The experiments were 
performed in MiRO5 buffer (110 mM sucrose, 60 mM 
potassium lactobionate, 0.5 mM EGTA, 1 g/l  BSA fat 
free, 3 mM MgCl2, 20 mM taurine, 10 mM KH2PO4,  
20 mM HEPES, pH 7.1).  
 
Defined respiratory states were obtained by a multiple 
substrate-inhibitor titration regime: malate 2mM, 
octanoylcarnitine 1 mM, ADP 5 mM, glutamate 10 
mM, succinate 10 mM, cytochrome c 10 µM, FCCP 
(stepwise, increments of 0.25 µM up to final 
concentration of maximally 1.25 µM), rotenone 0.5 µM, 
and antimycin A 2.5 µM. Cytochrome c was added to 
verify the intactness of the outer mitochondrial 
membrane after saponin permeabilization.   No visible 
stimulatory effect of cyt. c was observed in our 
conditions. If necessary, re-oxygenations were 
performed with pure oxygen.  
 
Bone marrow cells: Approximately 7×10
6 freshly 
isolated bone marrow cells were resuspended in 3 ml of 
Iscoves Modified Dulbecco’s Medium (Gibco) and 
applied for high-resolution respirometry as above. The 
experimental regime started with routine respiration 
(defined as endogenous respiration without additional 
substrates or effectors). After observing steady-state 
respiratory flux, the ATP synthase inhibitor oligomycin 
(1 µg/ml) was added, followed by uncoupling of 
oxidative phosphorylation by stepwise titration of FCCP 
(carbonyl cyanide p-trifluoromethoxyphenylhydrazone) 
up to optimum concentrations in the range of 2.5-4 µM. 
Finally, respiration was inhibited by complex I and 
compex III inhibitors rotenone (0,5 µM) and antimycin 
A (2,5 µM) respectively. 
 
The mitochondrial respiration data were normalized to 
the mitochondrial mass marker enzyme Citrate Synthase 
(CS) activity spectrophotometrically determined [70]. 
 
Quantitative Fluorescence In Situ Hybridization 
(qFISH). qFISH analysis was performed as previously 
described [71] in 5 uM liver and small intestine 
sections.  
 
Software and analysis of data.  FACS results were 
analyzed using FlowJo 7.2.2. Statistical analysis of the 
results was performed using Excel 2003 and 
GraphpadPrism 5.0 and image analysis with ImageJ 
1.39. Chemicapt 5000 ver 15.01 was used for 
acquisition of images from gels and western blots. 
Telomere fluorescence intensity was analyzed using the 
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